Stage IV Small Lymphocytic Lymphoma Active Not Recruiting Phase 1 Trials for Ibrutinib (DB09053)

IndicationStatusPhase
DBCOND0028635 (Stage IV Small Lymphocytic Lymphoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02160015Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by SurgeryTreatment